Our data showed the polymorphism of GSTP1 appears to be independent prognostic factors in osteosarcoma patients receiving chemotherapy, and GSTM1 and GSTT1 polymorphisms have no statistically significant association with osteosarcoma patients. The gene discussed is GSTM1; the disease is osteosarcoma.